Economic evaluation of clozapine for treatment resistant schizophrenia
Clozapine is the antipsychotic recommended for difficult to treat schizophrenia but the evidence on whether this drug is good value for money is limited. This project will compare the costs and effects in patients following the start of clozapine prescription with patients who are similar in terms of their characteristics but are not prescribed clozapine.